We also know that pegylated interferon alpha ... emerging from a prior PV or ET, or even pre-fibrotic, something that's closing into MF. What is your approach with interferons there?

Data reviewed in this article demonstrate that both interferon-ß-1a (IFNß-1a) and interferon-ß-1b (IFNß-1b) show a dose-response relationship in multiple sclerosis at current clinical doses.

Interferon-alfa (Intron A ... Yet doctors don't use radiation therapy very often for PV because it also can make blood cancer (leukemia) more likely. It’s normal to have a mix of emotions ...

PV can lead to cardiovascular complications ... emphasized that "BESREMi® is an innovative, monopegylated interferon with extended action due to its unique pharmacokinetic properties.